NEW YORK, Oct. 21, 2025 (GLOBE NEWSWIRE) -- Nasdaq, Inc. (Nasdaq: NDAQ) today reported financial results for the third quarter of 2025. Third quarter 2025 net revenue1 was $1.3 billion, an increase of 15% over the third quarter of 2024, or up 11% on an organic2 basis.

SAN DIEGO, Oct. 21, 2025 (GLOBE NEWSWIRE) -- iBio, Inc. (NASDAQ:IBIO), an AI-driven innovator of precision antibody therapies, today announced that Cory Schwartz, Ph.D., Director of Research and Early Development at iBio, will deliver an oral presentation at ObesityWeek 2025 November 4-7 in Atlanta. In addition, Martin Brenner, DVM, Ph.D., Chief Executive Officer and Chief Scientific Officer of iBio, will deliver an oral presentation at PEGS Europe 2025 November 11–13 in Lisbon.

WELLESLEY HILLS, Mass., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Climb Bio, Inc. (Nasdaq: CLYM), a clinical-stage biotechnology company developing therapeutics for immune-mediated diseases, today announced that it has strengthened its leadership team with the appointments of Adam Villa as Senior Vice President, Technical Operations, and Ashley Jones as Senior Vice President, People & Workforce Strategy.

NEW YORK, NY / ACCESS Newswire / October 21, 2025 / Reservoir Media, Inc. (NASDAQ:RSVR) ("Reservoir" or the "Company"), an award-winning independent music company, today announced that it will release financial results for the second fiscal quarter of 2026 ended September 30, 2025, before market open on Tuesday, November 4, 2025. Reservoir will host a conference call to discuss its results at 10 a.m.

Coca-Cola's revenue and profit exceeded Wall Street's third-quarter expectations on Tuesday, helped by resilient demand for its trademark sodas and zero-sugar beverages.

-- SIGNAL-AA Part B exceeded target enrollment based on demand from patients; trial size increased to 33 patients -- WALTHAM, Mass. , Oct. 21, 2025 /PRNewswire/ -- Q32 Bio Inc. (NASDAQ: QTTB) ("Q32 Bio"), a clinical stage biotechnology company focused on developing innovative therapies for alopecia areata (AA) and other autoimmune and inflammatory diseases, today announced that it has completed enrollment in Part B of its SIGNAL-AA Phase 2a clinical trial evaluating bempikibart in patients with severe or very severe AA.

Apple (NASDAQ: AAPL) shares surged to record highs on Monday, nearing the $4 trillion market capitalization milestone as new data revealed increased demand for the latest iPhone 17 lineup.

RTX delivers 12% sales growth with strong operational performance; Raises 2025 outlook for adjusted sales* and adjusted EPS*, confirms free cash flow* ARLINGTON, Va. , Oct. 21, 2025 /PRNewswire/ -- RTX (NYSE: RTX) reports third quarter 2025 results.

Sales of $6.3 billion Diluted EPS of $1.62 Adjusted Diluted EPS of $1.98 Updates 2025 Outlook: Revenue Growth to 3% to 4% from 1% to 3% Adjusted Diluted EPS to $7.50 to $7.75 from $7.50 to $8.00 ATLANTA , Oct. 21, 2025 /PRNewswire/ -- Genuine Parts Company (NYSE: GPC), a leading global service provider of automotive and industrial replacement parts and value-added solutions, announced today its results for the third quarter ended September 30, 2025. "Our third quarter results were in line with our expectations and demonstrate the ongoing execution of our strategic initiatives," said Will Stengel, President and Chief …

American Battery Technology (NASDAQ: ABAT) continues its showcase of extreme volatility following the cancellation of the $57.7 million Department of Energy (DOE) grant last week.

LONDON--(BUSINESS WIRE)--Pentair plc (NYSE: PNR), a leader in helping the world sustainably move, improve and enjoy water, life's most essential resource, today announced that Bob Fishman, Executive Vice President and Chief Financial Officer will be leaving the Company effective March 1, 2026 after six very successful years. Nick Brazis, Vice President of Corporate Development and Treasury will assume the role of Executive Vice President and Chief Financial Officer on March 1, 2026. The five-mo.

SAN DIEGO, Oct. 21, 2025 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Molina Healthcare, Inc. (NYSE: MOH) securities between February 5, 2025 and July 23, 2025, both dates inclusive (the “Class Period”), have until Tuesday, December 2, 2025 to seek appointment as lead plaintiff of the Molina class action lawsuit. Captioned Hindlemann v. Molina Healthcare, Inc., No. 25-cv-09461 (C.D. Cal.), the Molina Healthcare class action lawsuit charges Molina Healthcare and certain of Molina Healthcare's top executives with violations of the Securities Exchange Act of 1934.

BEACHWOOD, Ohio--(BUSINESS WIRE)--SITE Centers Corp. (NYSE: SITC), an owner of open-air shopping centers, today announced a special cash distribution on its common shares of $1.00 per common share payable on November 14, 2025 to shareholders of record at the close of business on October 31, 2025. About SITE Centers Corp. SITE Centers is an owner and manager of open-air shopping centers. The Company is a self-administered and self-managed REIT operating as a fully integrated real estate company,.

LONDON--(BUSINESS WIRE)--Pentair plc (NYSE: PNR), a leader in helping the world sustainably move, improve and enjoy water, life's most essential resource, today announced third quarter 2025 sales of $1,022 million. Sales were up 3 percent compared to sales for the same period last year. Excluding currency translation, acquisitions and divestitures, core sales grew 3 percent in the third quarter. Third quarter 2025 earnings per diluted share from continuing operations (“EPS”) were $1.12 compared.

Halliburton beat Wall Street estimates for third quarter profit on Tuesday, helped by steady demand for its oilfield equipment and services in North America.

Tuesday morning, 3M reported adjusted earnings per share of $2.19 from adjusted sales of $6.3 billion. Wall Street is looking for earnings per share of $2.07 from sales of $6.3 billion.

RAHWAY, N.J.--(BUSINESS WIRE)---- $MRK #MRK--Systematic Review of 15 Studies Focused on Epidemiology and Antimicrobial Resistance of Pneumococcal Serotypes Covered by CAPVAXIVE in U.S. Adults.

Third quarter revenues of $2.82 billion, up 13.1% from 2024 Third quarter reported diluted earnings per share ("EPS") of $2.16, up 8.5% from 2024; and adjusted diluted EPS of $2.60, up 13.0% from 2024 Year-to-date cash provided by operations of $1.4 billion, up 63.1% from 2024 Full year 2025 reported diluted EPS now expected to be between $8.58 and $8.66; and adjusted diluted EPS is expected to be between $9.76 and $9.84 SECAUCUS, N.J. , Oct. 21, 2025 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leading provider of diagnostic information services, today announced financial results for the third quarter …

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Pediatrix Medical Group 2025 Third Quarter Conference Call/Webcast Scheduled for Monday, November 3, 2025.

HAMPTON, N.H., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Unitil Corporation (NYSE: UTL) (unitil.com) has scheduled the release of its third quarter 2025 earnings after the market closes on November 3, 2025. Unitil will host its conference call and webcast on November 4, 2025 at 2:00 p.m. (ET) to review its quarterly results. Related presentation materials will be available before the call on the Company's Investors page at investors.unitil.com.